Abstract:
A comparative analysis of clinical, anamnestic and laboratory parameters of patients with COVID-19 was
carried out using the method of retrospective and prospective examination. It was found that during treatment
with antiviral drugs, a quarter of patients had changes of cytolysis markers. It was also shown that patients with
comorbidity were more common in a prospective study.
